Navigation Links
PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
Date:10/21/2009

PRINCETON, N.J., Oct. 21 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at the 8th Annual Partnerships in Clinical Trials Conference taking place at the World Trade Center in Rotterdam, The Netherlands from November 3-6, 2009.

At the conference, top management will discuss some of the most important issues to impact the industry growth and financial performance of CROs and their clients: the changing marketplace for drug development services, the industry's move to the fast growing emerging markets, and the clinical implications of developing biosimilar therapeutics.

Wednesday, 4 November 2009

Jeffrey P. McMullen, President and CEO of PharmaNet Development Group, will give a keynote presentation, "CRO Growth Opportunities in a More Challenging Market Environment."

Dr. Robert Reekie, Senior Executive Vice President Operations, Europe, Asia-Pacific, will chair a session entitled "Emerging Economies - Your Strategic Expansion for Cost Reduction and Patient Recruitment."

Thursday, 5 November 2009

Dr. Pablo Fernandez, Senior Vice President, Medical Affairs, will present "A Practical Overview of Outsourced Clinical Development for Biosimilars."

Conference attendees are invited to visit booth number 94 where PharmaNet Development Group's international team of experts will discuss how the Company helps clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com .

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    Email: ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
2. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Promising Cystic Fibrosis Compound on Track for Development
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
7. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
8. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
9. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
10. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
11. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose Inhalers, Dry Powder ... Respiratory Inhalers - our new study reveals trends, R&D progress, and ... you are involved in this sector you must read this brand ... streams to 2027, assessing data, trends, opportunities and business prospects there. ... Discover how to ...
(Date:3/29/2017)... 2017 Wound care devices and products are ... wound. The industry mainly consists of establishments engaged in ... of wounds caused by mechanical, chemical, thermal, and radiogenic ... as diabetes, skin related diseases, immunological diseases, and other ... was the largest region in the wound care devices ...
(Date:3/29/2017)... 2017  BioSpecifics Technologies Corp. (NASDAQ: BSTC), a ... collagenase based-therapies with a first in class collagenase-based ... ®  in the U.S. and Xiapex ®  in Europe, ... overview at the upcoming 16 th Annual ... at 8:00 a.m. ET in New ...
Breaking Medicine Technology:
(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... A ... suggests that following joint replacement surgery – the best place for a patient to ... when they are in familiar surroundings and have ample opportunity to rest and recover ...
(Date:3/30/2017)... Philadelphia, PA (PRWEB) , ... March 30, 2017 ... ... Wharton School is expanding its educational offerings of corporate finance programs to address ... a new program, will help executives increase their knowledge of sophisticated corporate finance ...
(Date:3/30/2017)... , ... March 30, 2017 , ... An inventor and manicurist from Greet, S.C., wants ... profession I try to help customers maintain clean and healthy feet, so I know the ... of their feet at home, I designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables ...
(Date:3/30/2017)... ... 30, 2017 , ... AudioEducator, a leader in training conferences ... Through Discharge Planning ” with noted expert Sue Dill Calloway, RN, MSN, JD., ... to prevent readmissions in light of the most recent programs at the Centers ...
(Date:3/29/2017)... ... March 29, 2017 , ... During the last week ... free screening colonoscopies to eligible individuals in the local community. , Colon cancer ... regular screenings can detect colon cancer while it is small, confined and easier to ...
Breaking Medicine News(10 mins):